drugset / Trial / NCT02525796
Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will evaluate whether blocking the mineralocorticoid receptor, alone, or in combination with the calcimimetic cinacalcet, can lower parathyroid hormone and calcium levels in primary hyperparathyroidism.
Timeline
- Start
- 2016-01
- Primary completion
- 2021-10-01
- Completion
- 2021-10-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amiloride | Small molecule | 10 mg | — |
| Subject | Eplerenone | Unknown | 50 mg | — |
| Background | Cinacalcet | Other / unclassified | 30 mg | — |